NCT05603130View on ClinicalTrials.gov

Epidemiologic Register on Diabetes and COVID-19 in Tunisia

CompletedOBSERVATIONAL
Enrollment

811

Participants

Timeline

Start Date

March 23, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

October 17, 2022

Conditions
COVID-19 Disease
Interventions
OTHER

routinely collected clinical information

medical history, epidemiological characteristics, clinical examination, biological assessment (blood glucose, NFS, CRP, D-dimer,etc...)

Trial Locations (1)

Unknown

Autoimmune diseases research unit UR17DN02, Department of Internal Medicine at the Military Hospital of Tunis, Tunis

All Listed Sponsors
lead

Les Laboratoires des Médicaments Stériles

INDUSTRY